PetMed Express, Inc.

PETS Healthcare Pharmaceutical Retailers

PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025.

Revenue
−19.9%
EPS
+83.0%
Free cash flow
+38.6%

Quarter to June 2026, against a year earlier

1.22 0.02 −1.61%
Market cap
$26.9M
P/E
0.0×
Fwd P/E
−2.4×
Dividend yield
—
F-score
3/9
Altman Z
0.40
Beneish M
−4.77
Dividend safety
36/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Total current assets
81.79 105.24 126.43 129.02 161.19 151.00 130.43 93.65 78.87 43.56
Total non-current assets
31.02 29.60 28.00 26.31 26.31 28.70 37.05 76.24 69.83 37.63
Total Assets
112.81 134.84 154.43 155.32 187.50 179.70 167.48 169.88 148.70 81.19
Total current liabilities
18.36 18.11 18.63 24.34 44.94 56.25 57.51 72.16 62.77 52.03
Total non-current liabilities
1.09 1.00 1.12 0.97 1.28 0.94 3.83 1.00 0.80 0.22
Total liabilities
19.44 19.11 19.75 25.31 46.22 56.25 57.51 73.15 63.57 52.25
Common Equity (Total)
93.36 115.72 134.67 130.00 141.27 123.44 109.96 96.72 85.13 28.93
Shareholders Equity (Total)
93.37 115.73 134.68 130.01 141.28 123.45 109.97 96.73 85.13 28.94

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026